Joris J Roelofs
Overview
Explore the profile of Joris J Roelofs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van Lienden K, Hoekstra L, van Trigt J, Roelofs J, van Delden O, van Gulik T
Hepatobiliary Pancreat Dis Int
. 2013 Dec;
12(6):622-9.
PMID: 24322748
Background: Portal vein embolization not only induces hypertrophy of the non-embolized liver, but also enhances tumor growth. The latter could be prevented by embolizing the hepatic arteries supplying the tumor-bearing...
12.
Muller M, Tuinman P, van der Sluijs K, Boon L, Roelofs J, Vroom M, et al.
Transfusion
. 2013 Sep;
54(4):996-1001.
PMID: 24032748
Background: Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-related morbidity and mortality. Anecdotally, TRALI patients have been treated with corticosteroids. However, evidence for its therapeutic rationale in...
13.
Vermeij J, Aslami H, Fluiter K, Roelofs J, van den Bergh W, Juffermans N, et al.
J Neurotrauma
. 2013 Aug;
30(24):2073-9.
PMID: 23937270
Traumatic brain injury (TBI) is frequently complicated by acute lung injury, which is predictive for poor outcome. However, it is unclear whether lung injury develops independently or as a result...
14.
Hofstra J, Cornet A, Declerck P, Dixon B, Aslami H, Vlaar A, et al.
PLoS One
. 2013 Feb;
8(2):e55262.
PMID: 23408962
Background: Critically ill patients frequently develop acute lung injury (ALI). Disturbed alveolar fibrin turnover, a characteristic feature of ALI, is the result of both activation of coagulation and inhibition of...
15.
Dik K, de Bruijne J, Takkenberg R, Roelofs J, Tempelmans M, Dijkgraaf M, et al.
Hepatol Res
. 2012 Oct;
42(11):1154-5.
PMID: 23094859
No abstract available.
16.
Dik K, de Bruijne J, Takkenberg R, Roelofs J, Tempelmans M, Dijkgraaf M, et al.
Hepatol Res
. 2012 Mar;
42(7):668-76.
PMID: 22385348
Aim: There is considerable variation in liver fibrosis stage and progression to cirrhosis among patients with chronic hepatitis B (CHB) or C (CHC). Coagulation pathway activity due to genetic variations...
17.
van den Esschert J, van Lienden K, Alles L, van Wijk A, Heger M, Roelofs J, et al.
Ann Surg
. 2012 Jan;
255(2):311-8.
PMID: 22241291
Objective: To compare the safety and hypertrophy response after portal vein embolization (PVE) using 2 absorbable and 3 permanent embolization materials. Background: Portal vein embolization is used to increase future...
18.
Cornet A, Hofstra J, Vlaar A, van den Boogaard F, Roelofs J, van der Poll T, et al.
Shock
. 2011 Sep;
36(4):417-23.
PMID: 21897338
Disturbed alveolar fibrin turnover is a characteristic feature of pneumonia. Inhibitors of coagulation could exert lung-protective effects via anticoagulant (inhibiting fibrin deposition) and possibly anti-inflammatory pathways, but could also affect...
19.
Wiersinga W, Kager L, Hovius J, van der Windt G, de Vos A, Meijers J, et al.
J Immunol
. 2010 Feb;
184(6):3079-86.
PMID: 20142364
Urokinase receptor (urokinase-type plasminogen activator receptor [uPAR], CD87), a GPI-anchored protein, is considered to play an important role in inflammation and fibrinolysis. The Gram-negative bacterium Burkholderia pseudomallei is able to...
20.
Hofstra J, Vlaar A, Cornet A, Dixon B, Roelofs J, Choi G, et al.
J Aerosol Med Pulm Drug Deliv
. 2010 Jan;
23(2):105-11.
PMID: 20073557
Background: Pulmonary coagulopathy may contribute to an adverse outcome in lung injury. We assessed the effects of local anticoagulant therapy on bronchoalveolar and systemic haemostasis in a rat model of...